Status:
UNKNOWN
Study Evaluating the Efficacy and Safety of Triptergium Wilfordii and Acitretin in Psoriasis Vulgaris - CHINA201002016-2
Lead Sponsor:
Ministry of Health, China
Conditions:
Psoriasis Vulgaris
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine whether Triptergium wilfordii, and Acitretin are effective and safe in the treatment of patient of moderate to severe psoriasis vulgaris.
Eligibility Criteria
Inclusion
- Adults of both sexes, between the age 18 and 75 years.
- Have a diagnosis of psoriasis vulgaris,PASI score of 7 or greater.
- Capable of giving informed consent and the consent must be obtained prior to any study related procedures.
Exclusion
- Currently have erythrodermic,guttate or pustular psoriasis.
- Have any active dermatoses which may affect disease assessment of psoriasis.
- Have used any investigational drug,any biologic or any systemic immunosuppressants within the previous 1 month..
- Have used topical medications/treatments that could affect psoriasis or PASI evaluation (eg, corticosteroids, tar, phototherapy et al.) within 2 weeks.
- Have any acute or chronic or recurrent infectious disease,which was difficult to control.
- Have the history of HBV or HCV infection,or HIV antibody test positive.
- AST, ALT or blood fat levels must be within 1.5 times the ULN range for the laboratory conducting the test.
- Are pregnant, nursing, or planning pregnancy in the coming two years(both men and women) while enrolled in the study.
- Have any severe systemic disease or have a history of malignancy.
- Have shown a previous hypersensitivity to Triptergium wilfordii or Acitretin.
- Have any other condition not suitable to join in trial,which are judged by investigator.
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
720 Patients enrolled
Trial Details
Trial ID
NCT01443338
Start Date
September 1 2011
Last Update
September 29 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Second Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China, 310009